vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and La Rosa Holdings Corp. (LRHC). Click either name above to swap in a different company.
La Rosa Holdings Corp. is the larger business by last-quarter revenue ($20.2M vs $13.8M, roughly 1.5× FENNEC PHARMACEUTICALS INC.). La Rosa Holdings Corp. runs the higher net margin — -27.4% vs -34.7%, a 7.4% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 3.2%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.
FENC vs LRHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $20.2M |
| Net Profit | $-4.8M | $-5.5M |
| Gross Margin | — | 8.4% |
| Operating Margin | -18.5% | -24.7% |
| Net Margin | -34.7% | -27.4% |
| Revenue YoY | 73.8% | 3.2% |
| Net Profit YoY | -141.1% | -125.7% |
| EPS (diluted) | $-0.17 | $-5.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | — | ||
| Q3 25 | $12.5M | $20.2M | ||
| Q2 25 | $9.7M | $23.2M | ||
| Q1 25 | $8.8M | $17.5M | ||
| Q4 24 | $7.9M | $17.7M | ||
| Q3 24 | $7.0M | $19.6M | ||
| Q2 24 | $7.3M | $19.1M | ||
| Q1 24 | $25.4M | $13.1M |
| Q4 25 | $-4.8M | — | ||
| Q3 25 | $-638.0K | $-5.5M | ||
| Q2 25 | $-3.2M | $78.4M | ||
| Q1 25 | $-1.2M | $-95.7M | ||
| Q4 24 | $-2.0M | $-5.1M | ||
| Q3 24 | $-5.7M | $-2.5M | ||
| Q2 24 | $-5.6M | $-2.3M | ||
| Q1 24 | $12.8M | $-4.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 8.4% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | — | 8.8% | ||
| Q4 24 | — | 8.9% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | — | 8.9% |
| Q4 25 | -18.5% | — | ||
| Q3 25 | -1.5% | -24.7% | ||
| Q2 25 | -28.3% | -10.6% | ||
| Q1 25 | -9.2% | -26.7% | ||
| Q4 24 | -11.8% | -17.1% | ||
| Q3 24 | -74.6% | -8.9% | ||
| Q2 24 | -69.4% | -9.7% | ||
| Q1 24 | 54.2% | -35.0% |
| Q4 25 | -34.7% | — | ||
| Q3 25 | -5.1% | -27.4% | ||
| Q2 25 | -32.7% | 337.8% | ||
| Q1 25 | -13.3% | -546.5% | ||
| Q4 24 | -25.0% | -28.7% | ||
| Q3 24 | -82.2% | -12.5% | ||
| Q2 24 | -76.5% | -12.2% | ||
| Q1 24 | 50.6% | -35.1% |
| Q4 25 | $-0.17 | — | ||
| Q3 25 | $-0.02 | $-5.44 | ||
| Q2 25 | $-0.11 | $15.25 | ||
| Q1 25 | $-0.04 | $-5.86 | ||
| Q4 24 | $-0.02 | $28.54 | ||
| Q3 24 | $-0.21 | $-16.49 | ||
| Q2 24 | $-0.20 | $-12.49 | ||
| Q1 24 | $0.41 | $-0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $4.0M |
| Total DebtLower is stronger | — | $642.8K |
| Stockholders' EquityBook value | $35.5M | $1.6M |
| Total Assets | $70.6M | $21.7M |
| Debt / EquityLower = less leverage | — | 0.41× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | — | ||
| Q3 25 | $21.9M | $4.0M | ||
| Q2 25 | $18.7M | $5.1M | ||
| Q1 25 | $22.7M | $2.9M | ||
| Q4 24 | $26.6M | $1.4M | ||
| Q3 24 | $40.3M | $1.8M | ||
| Q2 24 | $43.1M | $1.6M | ||
| Q1 24 | $51.2M | $1.1M |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | $642.8K | ||
| Q2 25 | $19.4M | $644.3K | ||
| Q1 25 | $19.4M | $645.9K | ||
| Q4 24 | $19.3M | $647.6K | ||
| Q3 24 | $32.1M | $649.2K | ||
| Q2 24 | $31.8M | $650.8K | ||
| Q1 24 | $31.3M | $652.4K |
| Q4 25 | $35.5M | — | ||
| Q3 25 | $-4.5M | $1.6M | ||
| Q2 25 | $-7.5M | $3.4M | ||
| Q1 25 | $-5.9M | $-87.5M | ||
| Q4 24 | $-5.9M | $2.6M | ||
| Q3 24 | $-5.2M | $5.0M | ||
| Q2 24 | $-1.4M | $4.7M | ||
| Q1 24 | $3.0M | $5.6M |
| Q4 25 | $70.6M | — | ||
| Q3 25 | $49.3M | $21.7M | ||
| Q2 25 | $44.9M | $22.9M | ||
| Q1 25 | $46.4M | $21.0M | ||
| Q4 24 | $44.9M | $19.4M | ||
| Q3 24 | $58.9M | $19.7M | ||
| Q2 24 | $63.2M | $18.7M | ||
| Q1 24 | $69.2M | $16.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.41× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | 10.40× | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $-1.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $1.5M | $-1.3M | ||
| Q2 25 | $-3.7M | $-1.4M | ||
| Q1 25 | $-4.3M | $-3.5M | ||
| Q4 24 | $-1.5M | $-1.1M | ||
| Q3 24 | $-2.2M | $-591.6K | ||
| Q2 24 | $-8.4M | $-803.1K | ||
| Q1 24 | $39.0M | $-538.3K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FENC
Segment breakdown not available.
LRHC
| Real Estate Residential Brokerage Services | $16.8M | 83% |
| Transferred Over Time | $3.5M | 17% |
